This inventor holds 5 USPTO granted patents. Top assignee: Other. Active years: 2012-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Toronto, CA (2012 - 2016)
- North York, CA (2017)
Company Filing History:
5 out of 834,601 Years Active: 2012-2017
Title: Innovations of Qinghua Wang in Obesity and Diabetes Treatment
Introduction
Qinghua Wang is a notable inventor based in Toronto, Canada, recognized for his contributions to the fields of obesity and diabetes treatment. With a total of five patents to his name, Wang has made significant strides in developing therapeutic interventions that target critical health issues.
Latest Patents
One of Wang's latest patents focuses on a growth hormone secretagogue receptor-based protein. This invention involves ghrelin, a peptide hormone that binds to its receptor, growth hormone secretagogue receptor 1a (GHS-R1a), promoting adiposity and obesity in mammals. The patent describes a soluble decoy GHS-R1a receptor that binds ghrelin in the periphery, preventing it from binding to GHS-R1 on cells. This innovative approach aims to antagonize ghrelin to treat obesity-related pathological conditions and cancer. The GHS-R1a is a transmembrane protein that comprises an N-terminal extracellular domain, seven transmembrane regions, and three extracellular loops. Wang's decoy GHS-R1a fusion protein, GHSR-Fc, has shown effectiveness in inhibiting adiposity and weight gain in mice on a high-fat diet.
Another significant patent involves a pharmaceutical composition for the treatment of type-1 diabetes. This composition combines a GABAergic and incretin, exemplified by GABA and GLP-1/Ex4, to promote beta-cell regeneration, prevent beta-cell apoptosis, and control autoimmunity. This innovative approach aims to provide a comprehensive solution for the prevention and treatment of type-1 diabetes in mammals.
Career Highlights
Throughout his career, Qinghua Wang has demonstrated a commitment to advancing medical science through his innovative inventions. His work has the potential to significantly impact the treatment of obesity and diabetes, addressing critical health challenges faced by many individuals.
Collaborations
Wang has collaborated with notable colleagues, including Gerald J Prud'homme and Mohan Basavaraju Kumar, to further enhance his research and development efforts.
Conclusion
Qinghua Wang's innovative contributions to obesity and diabetes treatment through his patents highlight his role as a leading inventor in the medical field. His work continues to pave the way for new therapeutic interventions that can improve health outcomes for many individuals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile